Literature DB >> 7942809

The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.

A A Lopes1, K Hornbuckle, S A James, F K Port.   

Abstract

To describe the joint effects of race and age on the risk of end-stage renal disease (ESRD) attributed to hypertension (ESRD-HT), we analyzed data for white and black adults, 20 to 84 years of age, reported by the United States Renal Data System during the period 1987 to 1990. The risk of ESRD-HT increased substantially with age for both blacks and whites; however, at each age, the risk was greater for blacks. A more in-depth description of the combination of effects involving race and age on ESRD-HT incidence was provided by two models of joint effects, one additive and the other multiplicative. Both models used the 20- to 24-year age group as the referent. Under the additive model the risk of ESRD-HT in blacks attributable to the joint effects between race and age increased continuously from younger to older groups. This indicates that although ESRD-HT risk increases with age for both blacks and whites, the increase for blacks is greater than expected if the effects of race were independent of the effects of age. However, the multiplicative model indicated that the proportional increase with age in ESRD-HT risk among blacks, as compared with whites, was more striking for younger ages (< or = 50 years among women and < or = 40 years among men), and especially so for men. This suggests a more accelerated course of hypertension toward ESRD for blacks (especially younger men) than for whites. A conceptual model to explain these patterns of race-age joint effects is proposed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7942809     DOI: 10.1016/s0272-6386(12)80211-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Life-course socioeconomic position and hypertension in African American men: the Pitt County Study.

Authors:  Sherman A James; John Van Hoewyk; Robert F Belli; David S Strogatz; David R Williams; Trevillore E Raghunathan
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

2.  The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  David Martins; Naureen Tareen; Ashraf Zadshir; Deyu Pan; Roberto Vargas; Allen Nissenson; Keith Norris
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

Review 3.  Stress, stress reduction, and hypertension in African Americans: an updated review.

Authors:  V Barnes; R Schneider; C Alexander; F Staggers
Journal:  J Natl Med Assoc       Date:  1997-07       Impact factor: 1.798

4.  Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.

Authors:  C I Obialo; K Hewan-Lowe
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

5.  On Learning and Visualizing Practice-based Clinical Pathways for Chronic Kidney Disease.

Authors:  Yiye Zhang; Rema Padman; Larry Wasserman
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

6.  Management of hypertension in the elderly patient at abidjan cardiology institute (ivory coast).

Authors:  K E Kramoh; E Aké-Traboulsi; C Konin; Y N'goran; I Coulibaly; A Adoubi; J Koffi; J B Anzouan-Kacou; M Guikahue
Journal:  Int J Hypertens       Date:  2011-10-18       Impact factor: 2.420

7.  Hypertensive target organ damage in Ghanaian civil servants with hypertension.

Authors:  Juliet Addo; Liam Smeeth; David A Leon
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

8.  Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population.

Authors:  Md Nurul Huda; Kazi Shahnoor Alam
Journal:  Int J Nephrol       Date:  2012-07-09

9.  High prevalence of target organ damage in young, African American inner-city men with hypertension.

Authors:  Wendy S Post; Martha N Hill; Cheryl R Dennison; James L Weiss; Gary Gerstenblith; Roger S Blumenthal
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.